Barry William Hancock

Summary

Affiliation: University of Sheffield
Country: UK

Publications

  1. pmc Survival from kidney cancer in England and Wales up to 2001
    B W Hancock
    Cancer Research Centre, Weston Park Hospital, Whitham Road, Sheffield S10 2SJ, UK
    Br J Cancer 99:S96-7. 2008
  2. ncbi Choriocarcinoma after a nonterm pregnancy
    Madeleine C Macdonald
    Department of Gynaecological Oncology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK
    J Reprod Med 55:213-8. 2010
  3. pmc High incidence of late effects found in Hodgkin's lymphoma survivors, following recall for breast cancer screening
    D M Greenfield
    Academic Unit of Clinical Oncology, Cancer Research Centre, University of Sheffield, Weston Park Hospital, Whitham Road, Sheffield S10 2SJ, UK
    Br J Cancer 94:469-72. 2006
  4. pmc High-dose chemotherapy and peripheral blood stem cell support in refractory gestational trophoblastic neoplasia
    L M El-Helw
    YCR Academic Unit of Clinical Oncology, Weston Park Hospital, Whitham Road, Sheffield S10 2SJ, UK
    Br J Cancer 93:620-1. 2005
  5. pmc Low-risk persistent gestational trophoblastic disease treated with low-dose methotrexate: efficacy, acute and long-term effects
    F Khan
    Trophoblastic Disease Centre, Academic Unit of Clinical Oncology, The University of Sheffield, Weston Park Hospital, Whitham Road, Sheffield S10 2SJ, UK
    Br J Cancer 89:2197-201. 2003
  6. pmc Second primary malignancies after treatment for malignant lymphoma
    A Okines
    YCR Academic Unit of Clinical Oncology, Weston Park Hospital, Sheffield, UK
    Br J Cancer 93:418-24. 2005
  7. pmc Atrial and placental melanoma metastasis: a case report and literature review
    Pradeep Lakshminarayana
    Department of Clinical Oncology, Weston Park Hospital, Whitham Road, Sheffield, S10 2SJ, UK
    J Med Case Reports 1:21. 2007
  8. ncbi hCG measurement in gestational trophoblastic neoplasia: a critical appraisal
    Barry W Hancock
    Trophoblastic Tumor Center, Sheffield, UK
    J Reprod Med 51:859-60. 2006
  9. ncbi Twin mole and viable fetus: The case for misdiagnosis
    Barry W Hancock
    Trophoblastic Tumour Centre, Weston Park Hospital, Sheffield, UK
    J Reprod Med 51:825-8. 2006
  10. ncbi Adjuvant interferon in high-risk melanoma: the AIM HIGH Study--United Kingdom Coordinating Committee on Cancer Research randomized study of adjuvant low-dose extended-duration interferon Alfa-2a in high-risk resected malignant melanoma
    B W Hancock
    Academic Unit of Clinical Oncology, The University of Sheffield, Weston Park Hospital, Whitham Rd, Sheffield S10 2SJ, UK
    J Clin Oncol 22:53-61. 2004

Collaborators

Detail Information

Publications27

  1. pmc Survival from kidney cancer in England and Wales up to 2001
    B W Hancock
    Cancer Research Centre, Weston Park Hospital, Whitham Road, Sheffield S10 2SJ, UK
    Br J Cancer 99:S96-7. 2008
  2. ncbi Choriocarcinoma after a nonterm pregnancy
    Madeleine C Macdonald
    Department of Gynaecological Oncology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK
    J Reprod Med 55:213-8. 2010
    ..To evaluate the characteristics and outcomes of patients with choriocarcinoma following a nonterm pregnancy and compare them to the results from the same unit of patients with choriocarcinoma following a term delivery...
  3. pmc High incidence of late effects found in Hodgkin's lymphoma survivors, following recall for breast cancer screening
    D M Greenfield
    Academic Unit of Clinical Oncology, Cancer Research Centre, University of Sheffield, Weston Park Hospital, Whitham Road, Sheffield S10 2SJ, UK
    Br J Cancer 94:469-72. 2006
    ..With increasing age, this patient group may suffer premature cardiac and respiratory morbidity...
  4. pmc High-dose chemotherapy and peripheral blood stem cell support in refractory gestational trophoblastic neoplasia
    L M El-Helw
    YCR Academic Unit of Clinical Oncology, Weston Park Hospital, Whitham Road, Sheffield S10 2SJ, UK
    Br J Cancer 93:620-1. 2005
    ..Three patients had partial tumour marker responses for 1-2 months. High-dose chemotherapy and HSCS for GTN is still unproven. Further studies are needed, perhaps in high-risk patients who fail their first salvage treatment...
  5. pmc Low-risk persistent gestational trophoblastic disease treated with low-dose methotrexate: efficacy, acute and long-term effects
    F Khan
    Trophoblastic Disease Centre, Academic Unit of Clinical Oncology, The University of Sheffield, Weston Park Hospital, Whitham Road, Sheffield S10 2SJ, UK
    Br J Cancer 89:2197-201. 2003
    ..7%), the outcome was successful. Methotrexate with folinic acid rescue is an effective treatment for low-risk persistent trophoblastic disease. It has minimal severe toxicity, excellent cure rates and does not appear to affect fertility...
  6. pmc Second primary malignancies after treatment for malignant lymphoma
    A Okines
    YCR Academic Unit of Clinical Oncology, Weston Park Hospital, Sheffield, UK
    Br J Cancer 93:418-24. 2005
    ..48; P = 0.068) after adjustment for other factors. Treatment modality was not statistically significant in any analysis. High stage at diagnosis of NHL may be a risk factor for developing a second primary cancer...
  7. pmc Atrial and placental melanoma metastasis: a case report and literature review
    Pradeep Lakshminarayana
    Department of Clinical Oncology, Weston Park Hospital, Whitham Road, Sheffield, S10 2SJ, UK
    J Med Case Reports 1:21. 2007
    ..A review of literature on cardiac and placental involvement of melanoma is also provided...
  8. ncbi hCG measurement in gestational trophoblastic neoplasia: a critical appraisal
    Barry W Hancock
    Trophoblastic Tumor Center, Sheffield, UK
    J Reprod Med 51:859-60. 2006
  9. ncbi Twin mole and viable fetus: The case for misdiagnosis
    Barry W Hancock
    Trophoblastic Tumour Centre, Weston Park Hospital, Sheffield, UK
    J Reprod Med 51:825-8. 2006
    ..To report the Sheffield Trophoblast Centre experience of twin molar gestations and review this in the light of international experience...
  10. ncbi Adjuvant interferon in high-risk melanoma: the AIM HIGH Study--United Kingdom Coordinating Committee on Cancer Research randomized study of adjuvant low-dose extended-duration interferon Alfa-2a in high-risk resected malignant melanoma
    B W Hancock
    Academic Unit of Clinical Oncology, The University of Sheffield, Weston Park Hospital, Whitham Rd, Sheffield S10 2SJ, UK
    J Clin Oncol 22:53-61. 2004
    ..To evaluate low-dose extended duration interferon alfa-2a as adjuvant therapy in patients with thick (> or = 4 mm) primary cutaneous melanoma and/or locoregional metastases...
  11. ncbi Staging and classification of gestational trophoblastic disease
    Barry William Hancock
    Trophoblastic Disease Unit Weston Park Hospital, Whitham Road, S10 2JS Sheffield, UK
    Best Pract Res Clin Obstet Gynaecol 17:869-83. 2003
    ..There is a need for globally agreed guidelines. This chapter addresses developments leading up to the recent publication of an internationally agreed staging/prognostic scoring system...
  12. ncbi Gestational trophoblastic neoplasia, an ancient disease: new light and potential therapeutic targets
    Mo iad Alazzam
    Department of Gynaecologic Oncology, Royal Hallamshire Hospital, Sheffield, UK
    Anticancer Agents Med Chem 10:176-85. 2010
    ..This review briefly summarises the recent advances in understanding the pathogenesis and molecular biology of this group of diseases and sheds light on molecules that could provide potential therapeutic targets...
  13. ncbi Transformed diffuse large B-cell lymphomas with gains of the discontinuous 12q12-14 amplicon display concurrent deregulation of CDK2, CDK4 and GADD153 genes
    Osama Al-Assar
    Yorkshire Cancer Research Institute for Cancer Studies, Division of Genomic Medicine, University of Sheffield, Sheffield, UK
    Br J Haematol 133:612-21. 2006
    ....
  14. ncbi Persistent gestational trophoblastic neoplasia after partial hydatidiform mole incidence and outcome
    Barry W Hancock
    Trophoblastic Tumour Centre, Weston Park Hospital, Sheffield, U K
    J Reprod Med 51:764-6. 2006
    ..To report the Sheffield experience with persistent gestational trophoblastic neoplasia (GTN) after partial hydatidiform mole (PHM) and to review worldwide experience...
  15. ncbi Screening for central nervous system disease in metastatic gestational trophoblastic neoplasia
    James Michael Price
    Academic Unit of Clinical Oncology, Weston Park Hospital, Sheffield, United Kingdom
    J Reprod Med 55:301-4. 2010
    ....
  16. ncbi Postpartum choriocarcinoma presentation, management and survival
    David Nugent
    Department of Gynaecological Oncology, Royal Hallamshire Hospital, Sheffield, UK
    J Reprod Med 51:819-24. 2006
    ..To determine the clinical presentation and outcome of postpartum choriocarcinoma...
  17. ncbi Management of persistent, unexplained, low-level human chorionic gonadotropin elevation: a report of 5 cases
    David Hwang
    Trophoblastic Disease Centre, Sheffield, UK
    J Reprod Med 49:559-62. 2004
    ....
  18. ncbi Treatment of metastatic gestational trophoblastic neoplasia
    Loaie M El-Helw
    Cancer Research Centre, Weston Park Hospital, Sheffield, UK
    Lancet Oncol 8:715-24. 2007
    ....
  19. ncbi A conservative approach in persistent low-level elevation of serum beta-human chorionic gonadotropin following chemotherapy for gestational trophoblastic neoplasia
    Melanie Boafo-Yirenki
    Sheffield Trophoblast Centre, Weston Park Hospital, Whitham Road, Sheffield, United Kingdom
    J Reprod Med 54:288-90. 2009
    ..To question whether patients with persistent low-level elevation of beta-human chorionic gonadotropin (beta-hCG) following chemotherapy for gestational trophoblastic neoplasia can be managed conservatively...
  20. ncbi Influence of age as a factor in the outcome of gestational trophoblastic neoplasia
    Julia E Palmer
    Department of Gynecological Oncology, Sheffield Teaching Hospitals NHS Trust, and Sheffield Trophoblastic Disease Centre, Sheffield, UK
    J Reprod Med 53:565-74. 2008
    ..To question whether older patients have a worse prognosis or poorer outcomes with chemotherapeutic regimens...
  21. pmc Chlorambucil versus observation after anti-Helicobacter therapy in gastric MALT lymphomas: results of the international randomised LY03 trial
    Barry W Hancock
    Department of Oncology, Weston Park Hospital, Sheffield UKLG, UK
    Br J Haematol 144:367-75. 2009
    ..58, P = 0.42). This is the first randomised trial to show there is no good evidence to support that additional single agent chemotherapy to anti-H. pylori treatment contributes to prevent recurrence in localised gastric MALT lymphomas...
  22. doi Does chest CT matter in the staging of GTN?
    Suzanne Darby
    Trophoblastic Tumour Centre, Weston Park Hospital, Sheffield, UK
    Gynecol Oncol 112:155-60. 2009
    ..The aim of this study is to determine whether or not CT scan significantly influences outcome of patients with GTN in terms of a need to change to second line chemotherapy or time to remission...
  23. ncbi Trials in advanced Hodgkin's disease: more than 30 years experience of the British National Lymphoma Investigation
    Jamal M Zekri
    Weston Park Hospital, Medical Oncology, Sheffield S10 2SJ, UK
    Clin Lymphoma 5:174-83. 2004
    ....
  24. ncbi Low-risk gestational trophoblastic neoplasia: evaluating the need for initial inpatient treatment during low-dose methotrexate chemotherapy
    Lucy D Carter
    Trophoblastic Tumour Centre, Weston Park Hospital, Sheffield, UK
    J Reprod Med 53:525-7. 2008
    ..To evaluate the need for initial inpatient treatment for patients being treated with low-dose intramuscular methotrexate for low-risk gestational trophoblastic neoplasia (GTN)...
  25. ncbi Localised non-Hodgkin lymphoma of the testis: the Sheffield Lymphoma Group experience
    Suzanne Darby
    Oncology Centre, Academic Unit of Clinical Oncology, Weston Park Hospital, Whitham Road, Sheffield S10 2SJ, UK
    Int J Oncol 26:1093-9. 2005
    ....
  26. ncbi Identification of novel regions of amplification and deletion within mantle cell lymphoma DNA by comparative genomic hybridization
    Jeannette E Allen
    Institute for Cancer Studies, Division of Genomic Medicine, University Medical School, Sheffield, UK
    Br J Haematol 116:291-8. 2002
    ..A greater understanding of the genetics of mantle cell lymphoma may allow the identification of prognostic factors which will aid the identification of appropriate treatment regimens...
  27. ncbi Molecular follow-up in gastric mucosa-associated lymphoid tissue lymphomas: early analysis of the LY03 cooperative trial
    Francesco Bertoni
    Department of Experimental Haematology, Barts and The London Queen Mary s School of Medicine and Dentistry, London, United Kingdom
    Blood 99:2541-4. 2002
    ..The presence of molecular disease in the absence of histologic disease does not appear to be associated with histologic relapse, but, given the indolent nature of MALT lymphomas, a longer follow-up is needed...